Accelerating compliance
and approvals with unmatched regulatory insight and experience.

Contact Us Today
The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.

Learn More About Us

Stay in the know

Sign up today for the Lachman Consultants blog.

Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.

    AREAS SERVED BY LACHMAN CONSULTANTS

    ADVANCE. CONFIDENTLY.

    As long-standing leaders in technical and regulatory consulting services, Lachman Consultants provides both experience and excellence through an unmatched team of respected industry professionals and SMEs.

    Mock FDA Audits

    Are you fully prepared for an inspection at your facility?

    Our team of experienced ex-FDA investigators offer comprehensive Mock FDA Audit services to help you prepare for an actual FDA inspection. Our team of experts will conduct a thorough inspection of your facility, review your documentation, and provide you with valuable feedback on areas that need improvement to ensure compliance with FDA regulations – both remotely and on-site.

    Learn More About Mock FDA Audits

    OnCall Image

    Recent Posts

    The Lachman Consultants Blog

    The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

    User Fees – How to Slice the Pizza – We Will Find Out Soon!

    I’m sure you’ve heard this question and answer before – “Q: Wo...
    Read More

    An Interesting Issue That May Impact FDA and Industry

    A Federal Register (FR) notice that appeared on today’s pre-publicat...
    Read More
    FDA Finalizes DESI Notice on Estrogen-Androgen

    After 50+ Years, FDA Finalizes DESI Notice on Estrogen-Androgen Fixed Combination Drug Products

    The Federal Register (FR) notice (here) appearing on today’s pre-pub...
    Read More

    Pharmacovigilance at Scale: Managing Complaints and Adverse Events for GLP-1 Products in a High-Volume Market

    The commercial landscape for GLP-1 products is very different than for...
    Read More
    New list of PSGs blog image

    FDA Announces the Publication of New Set of Product Specific Guidances

    In this morning’s Federal Register pre-notification page (here), the...
    Read More
    calm waters

    Mid-May OGD Approval Actions

    Through May 15, 2026, the OGD reports 26 full approval actions and 1...
    Read More
    ADVANCE CONFIDENTLY
    Contact Us Today